Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: Final results of a randomized, double-blind, placebo-controlled, phase 3 study

MLA

Urba, S., et al. “Pemetrexed in Combination with Cisplatin versus Cisplatin Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer: Final Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study.” Cancer, 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1366843295&authtype=sso&custid=ns315887.

APA

Urba, S., van Herpen, C. M., Sahoo, T. P., Shin, D. M., Licitra, L., Mezei, K., Reuter, C., Hitt, R., Russo, F., Chang, S. C., Hossain, A. M., Frimodt-Moller, B., Koustenis, A., & Hong, R. L. (2012). Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: Final results of a randomized, double-blind, placebo-controlled, phase 3 study. Cancer.

Chicago

Urba, S., C.M. van Herpen, T.P. Sahoo, D.M. Shin, L. Licitra, K. Mezei, C. Reuter, et al. 2012. “Pemetrexed in Combination with Cisplatin versus Cisplatin Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer: Final Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study.” Cancer. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1366843295&authtype=sso&custid=ns315887.